Related Links

                                                                                                                                                 
Welcome:
From Henry T. Lynch, M.D.                                                                           

As the Chairman of the Department of Preventive Medicine and President of the Hereditary Cancer Institute at Creighton University, I am very pleased to welcome you to the High Risk Registry website. Creighton University’s Hereditary Cancer Institute (HCI) has been granted the opportunity to host the High Risk Registry as an integral component of the Early Detection Research Network (EDRN) sponsored by the National Cancer Institute. This network is a collaborative group of over 25 of the top cancer research institutions nationwide and in Canada dedicated to cancer prevention through early detection. The Registry website is an extension of that goal. It will help to transmit a rich cross section of cancer related issues of particular importance to registry members as well as to the general public and medical professionals in a most expeditious manner.

At Creighton, we are especially excited about the Registry and the EDRN project as the Hereditary Cancer Institute has a long history spanning over thirty years of early cancer detection and prevention in relation to familial cancer. In three decades, HCI has amassed a large database of cancer affected families and have tried fervently to eradicate cancer development in these families by catching cancer at its earliest stages. With the creation of this collaborative network, the level of medical participation in tackling the goal of early cancer detection and prevention for not only familial cancer, but for all cancer types, will significantly increase. This is an unprecedented endeavor in cancer research and provides a very promising opportunity for improving medical practice in relation to cancer prevention.

The various sections of this website offer opportunities for increased cancer awareness in high risk individuals, and will also make available information detailing research studies aimed at cancer prevention. If you are an identified hereditary cancer gene mutation carrier, I hope that you will consider joining the High Risk Registry at Creighton University and further, participating in these early detection research studies. Your identity as a Registry member and all other personal information will not be made public. Therefore, your individual information will never appear on this website. For your convenience, this website provides information about joining the Registry, eligibility, confidentiality and ways in which to contact Creighton University for additional information.

With cancer being one of the leading causes of death, the Hereditary Cancer Institute at Creighton University looks forward to this collective opportunity for improving early cancer detection and prevention for the benefit of all. Thank you for your interest in this project and for visiting our website.
 
Sincerely,

Henry T. Lynch, M.D.
Medical Oncologist-Geneticist
Chairman, Department of Preventive Medicine
President, Hereditary Cancer Institute
Professor of Medicine
Creighton University School of Medicine

top